| Primary |
| Drug Use For Unknown Indication |
25.1% |
| Product Used For Unknown Indication |
18.2% |
| Cancer Pain |
14.8% |
| Pain |
14.4% |
| Drug Abuser |
3.9% |
| Prophylaxis |
3.8% |
| Back Pain |
3.7% |
| Drug Abuse |
2.8% |
| Constipation |
2.4% |
| Insomnia |
1.3% |
| Depression |
1.2% |
| Nausea |
1.2% |
| Hypertension |
1.2% |
| Nutritional Support |
1.0% |
| Breakthrough Pain |
1.0% |
| Lung Neoplasm Malignant |
0.9% |
| Renal Cell Carcinoma |
0.8% |
| Fluid Replacement |
0.8% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
| Analgesic Therapy |
0.7% |
|
| Respiratory Arrest |
19.4% |
| Completed Suicide |
8.7% |
| Cardio-respiratory Arrest |
8.6% |
| Death |
8.2% |
| Vomiting |
7.8% |
| Somnolence |
6.0% |
| Substance Abuse |
5.1% |
| Drug Abuse |
5.0% |
| Unresponsive To Stimuli |
4.3% |
| Delirium |
3.3% |
| Toxicity To Various Agents |
3.3% |
| Overdose |
3.1% |
| Poisoning |
2.8% |
| Cardiac Arrest |
2.6% |
| Serotonin Syndrome |
2.6% |
| Drug Abuser |
1.9% |
| Nausea |
1.9% |
| Pharmaceutical Product Complaint |
1.9% |
| Drug Dependence |
1.8% |
| Intentional Drug Misuse |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
24.6% |
| Drug Use For Unknown Indication |
21.0% |
| Cancer Pain |
15.9% |
| Pain |
10.8% |
| Prophylaxis |
5.5% |
| Constipation |
3.3% |
| Back Pain |
3.2% |
| Depression |
2.2% |
| Insomnia |
1.5% |
| Breakthrough Pain |
1.5% |
| Analgesic Therapy |
1.4% |
| Hypertension |
1.3% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Fibromyalgia |
1.1% |
| Breast Cancer |
1.1% |
| Ovarian Cancer |
0.9% |
| Malignant Neoplasm Of Renal Pelvis |
0.9% |
| Anxiety |
0.9% |
| Ill-defined Disorder |
0.9% |
| Diabetes Mellitus |
0.8% |
|
| Respiratory Arrest |
15.9% |
| Completed Suicide |
9.3% |
| Death |
7.7% |
| Somnolence |
7.5% |
| Toxicity To Various Agents |
6.9% |
| Vomiting |
6.1% |
| Drug Abuse |
6.0% |
| Drug Toxicity |
5.0% |
| Cardio-respiratory Arrest |
4.6% |
| Delirium |
4.1% |
| Multiple Drug Overdose |
3.4% |
| Cardiac Arrest |
3.3% |
| Intentional Drug Misuse |
2.9% |
| Poisoning |
2.9% |
| Nausea |
2.8% |
| White Blood Cell Count Decreased |
2.7% |
| Overdose |
2.7% |
| Insomnia |
2.5% |
| Unresponsive To Stimuli |
2.1% |
| Pain |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.3% |
| Drug Use For Unknown Indication |
15.5% |
| Pain |
15.0% |
| Multiple Myeloma |
5.2% |
| Hypertension |
3.9% |
| Depression |
3.5% |
| Nausea |
3.5% |
| Prophylaxis |
3.0% |
| Rheumatoid Arthritis |
2.9% |
| Constipation |
2.7% |
| Back Pain |
2.7% |
| Anxiety |
2.3% |
| Non-small Cell Lung Cancer |
2.2% |
| Insomnia |
2.0% |
| Crohn's Disease |
1.9% |
| Breast Cancer |
1.8% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Osteoporosis |
1.4% |
| Diabetes Mellitus |
1.4% |
| Breakthrough Pain |
1.3% |
|
| Vomiting |
16.9% |
| Weight Decreased |
9.6% |
| Death |
7.2% |
| Pain |
6.3% |
| Wrong Technique In Drug Usage Process |
5.3% |
| Pneumonia |
5.1% |
| Pyrexia |
4.7% |
| Pulmonary Embolism |
4.5% |
| Weight Increased |
4.3% |
| Nausea |
4.2% |
| White Blood Cell Count Decreased |
4.1% |
| Thrombocytopenia |
3.8% |
| Urinary Tract Infection |
3.2% |
| Renal Failure |
3.2% |
| Dyspnoea |
3.2% |
| Drug Ineffective |
3.1% |
| Renal Failure Acute |
3.0% |
| Rash |
2.9% |
| Tremor |
2.8% |
| Sepsis |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
33.9% |
| Drug Use For Unknown Indication |
10.1% |
| Pain |
10.1% |
| Depression |
6.2% |
| Neuralgia |
6.2% |
| Osteomyelitis Bacterial |
6.2% |
| Pain In Extremity |
6.2% |
| Antiemetic Supportive Care |
4.7% |
| Cancer Pain |
2.3% |
| Arthralgia |
1.9% |
| Fibromyalgia |
1.9% |
| Diabetes Mellitus |
1.6% |
| Ovarian Cancer |
1.6% |
| Psoriatic Arthropathy |
1.6% |
| Cardiac Disorder |
1.2% |
| Smoking Cessation Therapy |
1.2% |
| Back Pain |
0.8% |
| Constipation |
0.8% |
| Deep Vein Thrombosis |
0.8% |
| Hypertension |
0.8% |
|
| Drug Interaction |
14.3% |
| Inhibitory Drug Interaction |
12.7% |
| Drug Toxicity |
7.9% |
| Miosis |
6.3% |
| Surgery |
6.3% |
| Toxicity To Various Agents |
6.3% |
| Urinary Retention |
6.3% |
| Renal Cell Carcinoma Stage Unspecified |
4.8% |
| Bronchopneumonia |
3.2% |
| Fall |
3.2% |
| Hallucination |
3.2% |
| Neurotoxicity |
3.2% |
| Respiratory Depression |
3.2% |
| Sedation |
3.2% |
| Serotonin Syndrome |
3.2% |
| Subdural Haematoma |
3.2% |
| Swelling |
3.2% |
| Vomiting |
3.2% |
| Alcohol Interaction |
1.6% |
| Drug Administered At Inappropriate Site |
1.6% |
|